Home
NICE Guidance
NICE Advice
Medtech innovation briefings

FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care

Medtech innovation briefing [MIB114] Published: 31 July 2017

Advice

This advice has been updated and replaced by NICE medtech innovation briefing 224.